Investor Connect: Dr. Neal Vail Angel Investor/Progenerative Medical, Inc.

Investor Connect: Dr. Neal Vail Angel Investor/Progenerative Medical, Inc.

September 15, 2021 by investor

In this episode, Hall welcomes Dr. Neal Vail, angel investor and Chief Technical Officer/Co-founder at Progenerative Medical.

Progenerative Medical is a pre-commercialization stage medical device company focused on expanding clinically proven reduced pressure therapy into spinal and orthopedic indications. Their initial clinical application is to significantly improve clinical outcomes and satisfaction in patients undergoing spinal fusion procedures, a new annual revenue opportunity of $1.6B in the US market. They have the opportunity to expand the clinical use of their product into other orthopedic indications such as trauma, joint arthroplasty, and revision surgeries, all significantly larger markets than their initial indication.

Neal has 25+ years of medical device and pharmaceutical product R&D and commercialization experience. He has held positions of increasing technical, program management, and organizational leadership responsibilities at NEC America, Inc., DaimlerBenz Central Research, Southwest Research Institute, and Kinetic Concepts, Inc. Neal has assembled cross-functional teams to develop and execute successful product development programs funded through corporate, private and public stakeholders. He has experience in M&A and technology licensing. Neal has been an angel investor for about 15 years, reviewed 100s of investment opportunities, and invested in several startups. He has been a business strategy and technology advisor to several medical device start-ups. Neal graduated from UT-Austin with a Ph.D. in Chemical Engineering and has business training from the Sloan School at MIT.

Neal shares with Hall what led him to start working in the medical device and product development space. He discusses the state of startup investing, its evolution, and some of the challenges entrepreneurs face.

You can visit Progenerative Medical at www.progenerative.com, via LinkedIn at www.linkedin.com/in/progenmed/, and via Twitter at www.twitter.com/progenmed?lang=en

Neal can be contacted via email at nvail27@gmail.com, and via LinkedIn at www.linkedin.com/in/neal-vail-phd.  

For a full transcript, click here.

Music courtesy of Bensound.



Copyright (c) 2021, Hall Martin and investorconnect.org. All rights reserved.

Disclaimer:
Hall T Martin is the director of Investor Connect, which is a 501(c)(3) nonprofit dedicated to the education of investors for early-stage funding. All opinions expressed by Hall and podcast guests are solely their own opinions and do not reflect the opinion of Investor Connect. This podcast is for informational purposes only and should not be relied upon for the basis of investment decisions.

Tags: